RITUXAN Side Effects

6813641-9 | Progressive Multifocal Leukoencephalopathy
on Jun 23, 2010 Female patient from UNITED STATES , 69 years of age, was diagnosed with lupus-like syndrome, autoimmune thrombocytopenia and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy. Rituxan dosage: . During the same period patient was treated with PREDNISONE TAB (10 Mg, Qod) (View Prednisone Tab Review and Prednisone Tab Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SUMATRIPTAN SUCCINATE (Unk) (View Sumatriptan Succinate Review and Sumatriptan Succinate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6811248-0 | Myelodysplastic Syndrome
Patient was taking Rituxan (View Usage). Patient had the following side effects: myelodysplastic syndrome on Jun 23, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 198.9 lb, was diagnosed with mantle cell lymphoma and. Rituxan dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6810565-8 | Acute Respiratory Failure, Disseminated Intravascular Coagulation, Renal Failure
Adverse event was reported on Jun 23, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 617 A?g, 1/week) was diagnosed with systemic lupus erythematosus, anaemia haemolytic autoimmune and. Location: UNITED STATES , weighting 129.8 lb, After Rituxan was administered, patient had the following side effects: acute respiratory failure, disseminated intravascular coagulation, renal failure.

6810563-4 | Cellulitis, Infusion Site Extravasation, Paraesthesia
on Jun 23, 2010 Male patient from UNITED STATES , weighting 299.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), infusion site extravasation, paraesthesia. Rituxan dosage: 1325 Unk, Q4w. Patient was hospitalized.


6806376-X | Psoriasis, Systemic Lupus Erythematosus
on Jun 21, 2010 Female patient from ITALY , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). Patient had the following side effects: psoriasis, systemic lupus erythematosus. Rituxan dosage: 1000 Mg, Q2w.

6801646-3 | Infusion Related Reaction, Renal Failure Acute
Patient was taking Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: infusion related reaction, renal failure acute on Jun 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 183.0 lb, was diagnosed with b-cell lymphoma and. Rituxan dosage: 750 Mg, 4/week. During the same period patient was treated with HYDROCHLOROTHIAZIDE (12.5 Mg, Prn) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SUPPLEMENT NOS (Unk) (View Supplement Nos Review and Supplement Nos Label ).

6796319-X | Abscess, Cerebrovascular Accident, Hernia
Adverse event was reported on Jun 18, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 254.6 lb, Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), cerebrovascular accident, hernia (What is hernia?). During the same period patient was treated with DIAZEPAM (5 Mg, Tid) (View Diazepam Review and Diazepam Label ), SINGULAIR (View Singulair Review and Singulair Label ), MUCINEX D (View Mucinex D Review and Mucinex D Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), NASONEX (View Nasonex Review and Nasonex Label ), DUONEB (View Duoneb Review and Duoneb Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ).

6790944-8 | Chest Discomfort
on Jun 17, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). Patient had the following side effects: chest discomfort. Rituxan dosage: 1000 Mg, Unk. During the same period patient was treated with IMMUNOSUPPRESSANT NOS (View Immunosuppressant Nos Review and Immunosuppressant Nos Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6787251-6 | Neutropenia
on Jun 17, 2010 Female patient from UNITED STATES , 42 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: neutropenia. Rituxan dosage: . Patient was hospitalized.

6786886-4 | Gastric Ulcer
Patient was taking Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer on Jun 14, 2010 from UNITED STATES Additional patient health information: Female patient , 19 years of age, weighting 193.3 lb, was diagnosed with systemic lupus erythematosus and. Rituxan dosage: Unk. During the same period patient was treated with CELLCEPT (Unk) (View Cellcept Review and Cellcept Label ), IBUPROFEN (Unk) (View Ibuprofen Review and Ibuprofen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6785098-8 | Pancreatitis Acute
Adverse event was reported on Jun 14, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus and. Location: UNITED STATES , 19 years of age, weighting 193.3 lb, Patient had the following side effects: pancreatitis acute. During the same period patient was treated with CELLCEPT (Unk) (View Cellcept Review and Cellcept Label ), IBUPROFEN (Unk) (View Ibuprofen Review and Ibuprofen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DAPSONE (View Dapsone Review and Dapsone Label ). Patient was hospitalized.

6785064-2 | Gastritis
on Jun 15, 2010 Female patient from UNITED STATES , weighting 212.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hyperlipidaemia and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: gastritis. Rituxan dosage: 1000 Mg, Q6m. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6781103-3 | Eye Swelling, Throat Irritation
on Jun 17, 2010 Female patient from UNITED STATES , 35 years of age, weighting 187.0 lb, was diagnosed with arthropathy, vasculitis (What is vasculitis?) and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: eye swelling, throat irritation. Rituxan dosage: 1000 Mg X 1 Now Ther In 2 Wks Iv.

6780356-5 | Hepatitis B
Patient was taking Rituxan (View Usage). Patient had the following side effects: hepatitis b (What is hepatitis b?) on Jun 11, 2010 from JAPAN Additional patient health information: Male patient , 81 years of age, was diagnosed with chronic lymphocytic leukaemia and. Rituxan dosage: . Patient was hospitalized.

6780111-6 | Disorientation, Paresis, Reversible Posterior Leukoencephalopathy Syndrome
Adverse event was reported on Jun 11, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 375 Mg/m2, Unk) was diagnosed with non-hodgkin's lymphoma and. Location: JAPAN , weighting 99.21 lb, After Rituxan was administered, patient had the following side effects: disorientation, paresis, reversible posterior leukoencephalopathy syndrome. During the same period patient was treated with CYCLOPHOSPHAMIDE (1000 Mg, Qd) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE SULFATE (1.9 Mg, Qd) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISOLONE (100 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), SEROTONE (1 Unk, Unk) (View Serotone Review and Serotone Label ). Patient was hospitalized.

6776780-7 | Chills
on Jun 17, 2010 Male patient from UNITED STATES , 63 years of age, weighting 180.4 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: chills. Rituxan dosage: 800mg Every 28 Days Iv.

6776771-6 | Chills
on Jun 17, 2010 Male patient from UNITED STATES , 63 years of age, weighting 179.2 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan (View Usage). Patient had the following side effects: chills. Rituxan dosage: 800 Mg Every 28 Days. Iv.

6775661-2 | Diabetes Mellitus, Injection Site Discolouration, Rash
Patient was taking Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: diabetes mellitus, injection site discolouration, rash (What is rash?) on Jun 10, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, was diagnosed with thrombocytopenia and. Rituxan dosage: Unk.

6770220-X | Organ Failure
Adverse event was reported on Jun 07, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 375 Mg, Unk) . Location: UNITED STATES , 26 years of age, Patient experienced the following unwanted or unexpected effects: organ failure.

6766596-X | Pneumocystis Jiroveci Pneumonia
on Jun 01, 2010 Male patient from UNITED STATES , child 6 years of age, was diagnosed with dermatomyositis and was treated with Rituxan (View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia. Rituxan dosage: 750 Unk, Q14d. Patient was hospitalized.

6766204-8 | Anaemia Haemolytic Autoimmune, Arthralgia, Asthenia, Fatigue
on Jun 04, 2010 Female patient from UNITED STATES , weighting 170.0 lb, was diagnosed with anaemia haemolytic autoimmune and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: anaemia haemolytic autoimmune, arthralgia, asthenia, fatigue. Rituxan dosage: 375 Mg/m2, 1/week. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), AMBIEN (View Ambien Review and Ambien Label ).

6765070-4 | Anaphylactic Reaction, Hypersensitivity, Pruritus, Swollen Tongue
Patient was taking Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, hypersensitivity, pruritus, swollen tongue on Jun 09, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with chronic lymphocytic leukaemia and. Rituxan dosage: 375 Mg/m2 Once Ivpb. During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6764874-1 | Anaemia, Gastrointestinal Haemorrhage, Intestinal Obstruction
Adverse event was reported on Jun 02, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 205.5 lb, Patient had the following side effects: anaemia, gastrointestinal haemorrhage, intestinal obstruction. Patient was hospitalized.

6756064-3 | Cholestasis, Hepatic Cirrhosis, Hepatitis B, Lactic Acidosis
on May 24, 2010 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with chronic lymphocytic leukaemia, hepatitis b (What is hepatitis b?) and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: cholestasis, hepatic cirrhosis, hepatitis b (What is hepatitis b?), lactic acidosis. Rituxan dosage: Unk. During the same period patient was treated with FLUDARABINE (Unk) (View Fludarabine Review and Fludarabine Label ), CYTOXAN (Unk) (View Cytoxan Review and Cytoxan Label ), ENTECAVIR (Unk) (View Entecavir Review and Entecavir Label ), ADEFOVIR DIPIVOXIL KIT (Unk) (View Adefovir Dipivoxil Kit Review and Adefovir Dipivoxil Kit Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6754933-1 | Chest Pain, Palpitations
on May 27, 2010 Female patient from UNITED STATES , weighting 185.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), palpitations and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), palpitations. Rituxan dosage: 1000 Mg, Q4m. During the same period patient was treated with SOLU MEDROL (100 Mg, Unk) (View Solu-medrol Review and Solu-medrol Label ), KLONOPIN (1 Mg, Qhs) (View Klonopin Review and Klonopin Label ), DYAZIDE (1 Unk, Unk) (View Dyazide Review and Dyazide Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ), PAXIL (30 Mg, Qd) (View Paxil Review and Paxil Label ), XANAX (0.5 Mg, Prn) (View Xanax Review and Xanax Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6747591-3 | Encephalitis Enteroviral
Patient was taking Rituxan (View Usage). Patient had the following side effects: encephalitis enteroviral on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , 32 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Rituxan dosage: Unk. Patient was hospitalized.

6744963-8 | Lung Infection
Adverse event was reported on May 19, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: ) . Location: UNITED STATES , 37 years of age, After Rituxan was administered, patient had the following side effects: lung infection.

6743610-9 | Gastrointestinal Stromal Tumour
on May 19, 2010 Female patient from UNITED STATES , 56 years of age, was diagnosed with mantle cell lymphoma and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal stromal tumour. Rituxan dosage: Unk.

6740681-0 | Leukocytoclastic Vasculitis, Pyrexia, Rash
on May 19, 2010 Male patient from UNITED STATES , weighting 181.5 lb, was diagnosed with b-cell lymphoma and was treated with Rituxan (View Usage). Patient had the following side effects: leukocytoclastic vasculitis, pyrexia, rash (What is rash?). Rituxan dosage: 754 Mg, Q3m. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6740343-X | Acute Respiratory Failure, Disseminated Intravascular Coagulation, Renal Failure
Patient was taking Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: acute respiratory failure, disseminated intravascular coagulation, renal failure on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 129.8 lb, was diagnosed with systemic lupus erythematosus, anaemia haemolytic autoimmune and. Rituxan dosage: 617 A?g, Unk.

6740329-5 | Muscular Weakness, Neurological Symptom
Adverse event was reported on May 18, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: 1000 Mg, Days 1+15) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: muscular weakness, neurological symptom.

6736526-5 | Confusional State, Memory Impairment, Pyrexia
on May 14, 2010 Female patient from UNITED STATES , 32 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rituxan (View Usage). Patient had the following side effects: confusional state, memory impairment, pyrexia. Rituxan dosage: Unk. Patient was hospitalized.

6731628-1 | Chills, Infusion Related Reaction, Pyrexia, Rash, Tremor
on May 18, 2010 Female patient from UNITED STATES , weighting 57.98 lb, was diagnosed with thrombocytopenic purpura and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: chills, infusion related reaction, pyrexia, rash (What is rash?), tremor. Rituxan dosage: . Patient was hospitalized.

6731433-6 | Blood Calcium Decreased, Blood Magnesium Decreased, Blood Sodium Decreased, Candidiasis, Clostridium Difficile Colitis, Confusional State, Device Related Infection, Febrile Neutropenia, Herpes Simplex
Patient was taking Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: blood calcium decreased, blood magnesium decreased, blood sodium decreased, candidiasis, clostridium difficile colitis, confusional state, device related infection, febrile neutropenia, herpes simplex (What is herpes simplex?) on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 160.0 lb, was diagnosed with non-hodgkin's lymphoma and. Rituxan dosage: Every 3 Weeks Iv. During the same period patient was treated with C H O P (View C-h-o-p Review and C-h-o-p Label ). Patient was hospitalized.

6731432-4 | Anaemia, Blood Calcium Decreased, Blood Potassium Decreased, Blood Sodium Decreased, Febrile Neutropenia, Hypotension, Infection
Adverse event was reported on May 18, 2010 by a Male patient taking Rituxan (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 59 years of age, weighting 150.0 lb, Patient had the following side effects: anaemia, blood calcium decreased, blood potassium decreased, blood sodium decreased, febrile neutropenia, hypotension, infection (What is infection?). During the same period patient was treated with C H O P (View C-h-o-p Review and C-h-o-p Label ). Patient was hospitalized.

6731430-0 | Anaemia, Febrile Neutropenia, Infection
on May 18, 2010 Male patient from UNITED STATES , 59 years of age, weighting 150.0 lb, was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: anaemia, febrile neutropenia, infection (What is infection?). Rituxan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6731429-4 | Anaemia, Asthenia, Febrile Neutropenia, Hypotension, Infection
on May 18, 2010 Male patient from UNITED STATES , 59 years of age, weighting 148.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, febrile neutropenia, hypotension, infection (What is infection?). Rituxan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6731428-2 | Anaemia, Candidiasis, Oesophagitis
Patient was taking Rituxan (View Usage). Patient had the following side effects: anaemia, candidiasis, oesophagitis on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 136.0 lb, was diagnosed with non-hodgkin's lymphoma and. Rituxan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6731427-0 | Anaemia, Febrile Neutropenia, Hypotension, Infection
Adverse event was reported on May 18, 2010 by a Male patient taking Rituxan (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 59 years of age, weighting 143.0 lb, After Rituxan was administered, patient had the following side effects: anaemia, febrile neutropenia, hypotension, infection (What is infection?). During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6731426-9 | Asthenia, Febrile Neutropenia, Hypotension, Infection, Oesophagitis, Pancytopenia, Troponin Increased
on May 18, 2010 Male patient from UNITED STATES , 59 years of age, weighting 136.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, febrile neutropenia, hypotension, infection (What is infection?), oesophagitis, pancytopenia, troponin increased. Rituxan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6731425-7 | Anaemia, Blood Magnesium Decreased, Infection
on May 18, 2010 Male patient from UNITED STATES , 59 years of age, weighting 155.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan (View Usage). Patient had the following side effects: anaemia, blood magnesium decreased, infection (What is infection?). Rituxan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6731424-5 | Anaemia, Febrile Neutropenia, Infection
Patient was taking Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: anaemia, febrile neutropenia, infection (What is infection?) on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 148.0 lb, . Rituxan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6731366-5 |
Adverse event was reported on May 10, 2010 by a Female patient taking Rituxan (View Usage) (Dosage: ) . Location: UNITED STATES , 77 years of age, .

6727995-5 | Optic Neuropathy
on May 10, 2010 Female patient from UNITED STATES , weighting 95.98 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan (View Usage). Patient had the following side effects: optic neuropathy. Rituxan dosage: Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ).

6726094-6 | Rectal Haemorrhage
on May 07, 2010 Female patient from UNITED STATES , weighting 307.9 lb, was diagnosed with colitis ulcerative and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: rectal haemorrhage. Rituxan dosage: Unk. During the same period patient was treated with REMICADE (Unk, Q8w) (View Remicade Review and Remicade Label ), AZATHIOPRINE (Unk) (View Azathioprine Review and Azathioprine Label ).

6724607-1 | Leukocytoclastic Vasculitis, Pyrexia, Rash
Patient was taking Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis, pyrexia, rash (What is rash?) on May 05, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 180.0 lb, was diagnosed with non-hodgkin's lymphoma, b-cell lymphoma and. Rituxan dosage: Unk. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6724441-2 | Neutrophil Count Decreased, Vertigo Positional, White Blood Cell Count Decreased
Adverse event was reported on May 07, 2010 by a Male patient taking Rituxan (View Usage) (Dosage: 250 Mg/m2, Single) was diagnosed with mantle cell lymphoma and. Location: JAPAN , 64 years of age, Patient had the following side effects: neutrophil count decreased, vertigo positional, white blood cell count decreased. During the same period patient was treated with ZEVALIN (View Zevalin Review and Zevalin Label ), FAMOTIDINE (40 Mg, Qd) (View Famotidine Review and Famotidine Label ), CYANOCOBALAMIN (1500 A?g, Qd) (View Cyanocobalamin Review and Cyanocobalamin Label ), ENTERONON R (3 G, Qd) (View Enteronon-r Review and Enteronon-r Label ), ALLOPURINOL (100 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), AMLODIPINE BESYLATE (2.5 G, Qd) (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6717531-1 | Dyspnoea, Flushing, Palpitations, Throat Tightness
on May 07, 2010 Male patient from UNITED STATES , 54 years of age, weighting 145.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan (View Usage). After Rituxan was administered, patient had the following side effects: dyspnoea, flushing, palpitations, throat tightness. Rituxan dosage: 800 Mg One Time Iv.

6714460-4 | Pneumocystis Jiroveci Pneumonia
on Apr 30, 2010 Male patient from JAPAN , 39 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan (View Usage). Patient experienced the following unwanted or unexpected effects: pneumocystis jiroveci pneumonia. Rituxan dosage: . Patient was hospitalized.

6710614-1 | Progressive Multifocal Leukoencephalopathy
Patient was taking Rituxan (View Usage). Patient had the following side effects: progressive multifocal leukoencephalopathy on Apr 26, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, was diagnosed with b-cell lymphoma and. Rituxan dosage: 1 Unk, Q3m. Patient was hospitalized.